Increase in PI3K signalling mimics mutated-Kras induction of pancreatic cancer

被引：3
|
作者：
Baer, R. [1 ]
Pyronnet, S. [1 ]
Guillermet-Guibert, J. [1 ]
机构：
[1] Univ Toulouse 3, CHU Rangueil, CRCT, INSERM,UMR 1037, F-31432 Toulouse, France
来源：
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY | 2013年 / 37卷 / 04期
关键词：
ADENOCARCINOMA;
D O I：
10.1016/j.clinre.2013.04.006
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：320 / 321
页数：2
相关论文
共 50 条
  • [1] Nuclear PI3K signalling in colorectal cancer
    Palmieri, M.
    Catimel, B.
    Holmes, A.
    Sieber, O.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S123 - S123
  • [2] PI3K/Akt signalling pathway and cancer
    Vara, JAF
    Casado, E
    de Castro, J
    Cejas, P
    Belda-Iniesta, C
    González-Barón, M
    CANCER TREATMENT REVIEWS, 2004, 30 (02) : 193 - 204
  • [3] Attenuating PI3K isoforms in pancreatic cancer: Focus on immune PI3Kγ
    Basset, C.
    Guillermet-Guibert, J.
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2017, 41 (04) : 351 - 353
  • [4] PI3K signalling in inflammation
    Hawkins, P. T.
    Stephens, L. R.
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2015, 1851 (06): : 882 - 897
  • [5] A MEK/PI3K/HDAC inhibitor combination therapy for KRAS mutant pancreatic cancer cells
    Ischenko, Irene
    Petrenko, Oleksi
    Hayman, Michael J.
    ONCOTARGET, 2015, 6 (18) : 15814 - 15827
  • [6] Phosphoinositide signalling in cancer: beyond PI3K and PTEN
    Bunney, Tom D.
    Katan, Matilda
    NATURE REVIEWS CANCER, 2010, 10 (05) : 342 - 352
  • [7] Phosphoinositide signalling in cancer: beyond PI3K and PTEN
    Tom D. Bunney
    Matilda Katan
    Nature Reviews Cancer, 2010, 10 : 342 - 352
  • [8] Dual Inhibition of MEK and PI3K Pathway in KRAS and BRAF Mutated Colorectal Cancers
    Temraz, Sally
    Mukherji, Deborah
    Shamseddine, Ali
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2015, 16 (09): : 22976 - 22988
  • [9] The type of KRAS mutation drives PI3Kα/γ signalling dependency: Implication for the choice of targeted therapy in pancreatic adenocarcinoma patients
    Cayron, Coralie
    Guillermet-Guibert, Julie
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2021, 45 (01)
  • [10] Targeting the PI3K Signalling as a Therapeutic Strategy in Colorectal Cancer
    Fernandes, Maria Sofia
    Sanches, Joao Miguel
    Seruca, Raquel
    TARGETED THERAPY OF COLORECTAL CANCER SUBTYPES, 2018, 1110 : 35 - 53
12345